Pier Paolo Pandolfi

Pier Paolo Pandolfi

Harvard University

H-index: 172

North America-United States

About Pier Paolo Pandolfi

Pier Paolo Pandolfi, With an exceptional h-index of 172 and a recent h-index of 94 (since 2020), a distinguished researcher at Harvard University,

His recent articles reflect a diverse array of research interests and contributions to the field:

MicroRNA-22 is a key regulator of lipid and metabolic homeostasis

Synthetic methodologies and therapeutic potential of indole-3-carbinol (I3C) and its derivatives

METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer

Methods for dual dna/protein tagging of open chromatin

Inhibitors of micro-rna 22

Stroma-derived miR-214 coordinates tumor dissemination

Targeting of microRNA-22 Suppresses Tumor Spread in a Mouse Model of Triple-Negative Breast Cancer

Correction to: STAT3-dependent long non-coding RNA Lncenc1 contributes to mouse ES cells pluripotency via stabilizing Klf4 mRNA

Pier Paolo Pandolfi Information

University

Harvard University

Position

Director, Cancer Center and Cancer Research Institute, Beth Israel Deaconess Medical Center

Citations(all)

125821

Citations(since 2020)

37220

Cited By

104271

hIndex(all)

172

hIndex(since 2020)

94

i10Index(all)

493

i10Index(since 2020)

368

Email

University Profile Page

Harvard University

Top articles of Pier Paolo Pandolfi

Title

Journal

Author(s)

Publication Date

MicroRNA-22 is a key regulator of lipid and metabolic homeostasis

International Journal of Molecular Sciences

Riccardo Panella

Andreas Petri

Bhavna N Desai

Sharmila Fagoonee

Cody A Cotton

...

2023/8/17

Synthetic methodologies and therapeutic potential of indole-3-carbinol (I3C) and its derivatives

Pharmaceuticals

Federica Centofanti

Alessandro Buono

Michele Verboni

Carlo Tomino

Simone Lucarini

...

2023/2/5

METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer

Molecular cancer

Raquel García-Vílchez

Ana M Añazco-Guenkova

Sabine Dietmann

Judith López

Virginia Morón-Calvente

...

2023/7/29

Methods for dual dna/protein tagging of open chromatin

2023/1/26

Inhibitors of micro-rna 22

2023/6/15

Stroma-derived miR-214 coordinates tumor dissemination

Journal of Experimental & Clinical Cancer Research

Francesca Orso

Federico Virga

Daniela Dettori

Alberto Dalmasso

Mladen Paradzik

...

2023/1/13

Targeting of microRNA-22 Suppresses Tumor Spread in a Mouse Model of Triple-Negative Breast Cancer

Biomedicines

Riccardo Panella

Cody A Cotton

Valerie A Maymi

Sachem Best

Kelsey E Berry

...

2023/5/18

Correction to: STAT3-dependent long non-coding RNA Lncenc1 contributes to mouse ES cells pluripotency via stabilizing Klf4 mRNA

Marco E Bianchi Carbognin

Graziano Martello

Salvatore Oliviero

Pier Paolo Pandolfi

Valeria Poli

2023

STAT3-dependent long non-coding RNA Lncenc1 contributes to mouse ES cells pluripotency via stabilizing Klf4 mRNA

Briefings in Functional Genomics

Emanuele Monteleone

Paola Corrieri

Paolo Provero

Daniele Viavattene

Lorenzo Pulvirenti

...

2023/10/4

Micro-RNA and obesity

2023/9/12

Two’s Company, Three’sa Crowd: Rb1/Trp53/Pten Trifecta and Lung Cancer Molecular and Histopathologic Heterogeneity

Journal of Thoracic Oncology

Lamis Yehia

Maria Laura Centomo

Pier Paolo Pandolfi

Charis Eng

2023/3/1

Indole-3-carbinol in vitro antiviral activity against SARS-Cov-2 virus and in vivo toxicity

Cell Death Discovery

Federica Centofanti

Tonino Alonzi

Andrea Latini

Paola Spitalieri

Michela Murdocca

...

2022/12/15

Micro-RNA inhibitors and their uses in disease

2022/3/15

PTEN in Immunity

Antonella Papa

Pier Paolo Pandolfi

2022/10/16

The HECT family of E3 ubiquitin ligases and PTEN

Min Sup Song

Pier Paolo Pandolfi

2022/10/1

Pyruvate kinase M1 suppresses development and progression of prostate adenocarcinoma

Cancer research

Shawn M Davidson

Daniel R Schmidt

Julia E Heyman

James P O'Brien

Amy C Liu

...

2022/7/5

An immunocompetent environment unravels the proto-oncogenic role of miR-22

Maria Laura Centomo

Marianna Vitiello

Laura Poliseno

Pier Paolo Pandolfi

2022/12/19

Two different therapeutic approaches for SARS-CoV-2 in hiPSCs-derived lung organoids

Cells

Paola Spitalieri

Federica Centofanti

Michela Murdocca

Maria Giovanna Scioli

Andrea Latini

...

2022/4/5

Skp2 dictates cell cycle-dependent metabolic oscillation between glycolysis and TCA cycle

Cell research

Jing Liu

Yunhua Peng

LE Shi

Lixin Wan

Hiroyuki Inuzuka

...

2021/1

In vivo silencing/overexpression of lncRNAs by CRISPR/Cas system

Marianna Vitiello

Laura Poliseno

Pier Paolo Pandolfi

2021/6/24

See List of Professors in Pier Paolo Pandolfi University(Harvard University)

Pier Paolo Pandolfi FAQs

What is Pier Paolo Pandolfi's h-index at Harvard University?

The h-index of Pier Paolo Pandolfi has been 94 since 2020 and 172 in total.

What are Pier Paolo Pandolfi's top articles?

The articles with the titles of

MicroRNA-22 is a key regulator of lipid and metabolic homeostasis

Synthetic methodologies and therapeutic potential of indole-3-carbinol (I3C) and its derivatives

METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer

Methods for dual dna/protein tagging of open chromatin

Inhibitors of micro-rna 22

Stroma-derived miR-214 coordinates tumor dissemination

Targeting of microRNA-22 Suppresses Tumor Spread in a Mouse Model of Triple-Negative Breast Cancer

Correction to: STAT3-dependent long non-coding RNA Lncenc1 contributes to mouse ES cells pluripotency via stabilizing Klf4 mRNA

...

are the top articles of Pier Paolo Pandolfi at Harvard University.

What is Pier Paolo Pandolfi's total number of citations?

Pier Paolo Pandolfi has 125,821 citations in total.